)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Caliway Biopharmaceuticals
Caliway Biopharmaceuticals (6919) investor relations material
Caliway Biopharmaceuticals Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary16 Jun, 2026
Executive summary
Focused on new drug development for aesthetic medicine and chronic inflammation, with shares listed on TWSE since October 2024.
Consolidated financials reviewed for Q1 2026 and Q1 2025, with a qualified conclusion due to unreviewed non-significant subsidiaries.
Main revenue source is health food sales; operates as a single segment.
Financial highlights
Q1 2026 operating revenue was $2 thousand, down from $50 thousand in Q1 2025.
Net loss for Q1 2026 was $107,754 thousand, improved from $175,565 thousand in Q1 2025.
Basic loss per share was $0.07 in Q1 2026, compared to $0.11 in Q1 2025.
Cash and cash equivalents at March 31, 2026 were $2,539,089 thousand, down from $9,297,482 thousand at March 31, 2025.
Total assets at March 31, 2026 were $9,536,630 thousand, with equity of $9,362,838 thousand.
Outlook and guidance
Evaluating the impact of IFRS 18, which will be adopted in Taiwan in 2028; no significant impact expected from other new standards.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Caliway Biopharmaceuticals
- Revenue up 14% but net loss deepened; capital raised, customer concentration risk persists.6919
Q4 20242 Jun 2026 - Q1 2025 net loss narrowed to $175,565 thousand on revenue of $3,966 thousand.6919Q1 20252 Jun 2026
- Net loss widened on higher expenses and FX losses, despite stable revenue and improved cash.6919Q2 20252 Jun 2026
- Net loss narrowed and equity strengthened amid lower revenue and major capital actions.6919Q3 20252 Jun 2026
- Net loss narrowed in 2025 amid strong equity and ongoing R&D investment.6919Q4 20252 Jun 2026
- CBL-514 delivers targeted, non-surgical fat reduction with strong efficacy, safety, and market potential.6919Investor presentation2 Jun 2026
Next Caliway Biopharmaceuticals earnings date
Q2 202610 Aug, 2026
Caliway Biopharmaceuticals
Next Caliway Biopharmaceuticals earnings date
Q2 202610 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage